COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT03085095
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03085095
Recruitment Status : Recruiting
First Posted : March 21, 2017
Last Update Posted : October 29, 2020
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : October 25, 2019
Estimated Study Completion Date : November 1, 2021
Certification/Extension First Submitted : October 5, 2020